Literature DB >> 19916744

Upregulation of SEPT7 gene inhibits invasion of human glioma cells.

Song Xu1, Zhi-Fan Jia, Chunsheng Kang, Qiang Huang, Guangxiu Wang, Xiaozhi Liu, Xuan Zhou, Peng Xu, Peiyu Pu.   

Abstract

OBJECTIVES: To explore the role of SEPT7 in glioma cell invasion.
METHODS: SEPT7 was transfected into human glioma cell lines U251 and TJ899, the invasive abilities were evaluated by transwell assay, scratch assay, and 3-D/2-D Matrigel growth. The expression of MMP2/9, MT1-MMP, integrin alpha(v)beta(3), and TIMP1/2 was detected by immunohistochemistry, immunofluorescence, and Western blot analyses. Distribution of alpha-tubulin was examined by laser scanning confocal analysis. RESULT: After SEPT7 trasfection, cell invasion was inhibited, expression of MMP2/9, MT1-MMP, and integrin alpha(v)beta(3) was decreased, while TIMP1/2 was increased, and alpha-tubulin was redistributed.
CONCLUSION: These results suggest that SEPT7 plays an important role in the glioma cell invasion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19916744     DOI: 10.3109/07357900903179609

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  4 in total

1.  MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.

Authors:  Xiao Yue; Dechen Cao; FengMing Lan; Qiang Pan; Tingyi Xia; Huiming Yu
Journal:  Neuro Oncol       Date:  2016-03-22       Impact factor: 12.300

Review 2.  3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages.

Authors:  Ola Habanjar; Mona Diab-Assaf; Florence Caldefie-Chezet; Laetitia Delort
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

3.  The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.

Authors:  Lobna Elkhadragy; Hadel Alsaran; Weiwen Long
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

4.  The role of septin 7 in physiology and pathological disease: A systematic review of current status.

Authors:  Xinlu Wang; Fei Fei; Jie Qu; Chunyuan Li; Yuwei Li; Shiwu Zhang
Journal:  J Cell Mol Med       Date:  2018-03-30       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.